SBIR-STTR Award

Encapsulation of Biological Contaminants in Transportation Systems
Award last edited on: 6/19/2018

Sponsored Program
SBIR
Awarding Agency
EPA
Total Award Amount
$399,795
Award Phase
2
Solicitation Topic Code
15-NCER-07
Principal Investigator
Kevin Beltis

Company Information

TIAX LLC

35 Hartwell Avenue
Lexington, MA 02421
   (781) 879-1200
   info@tiaxllc.com
   www.tiaxllc.com
Location: Multiple
Congr. District: 05
County: Middlesex

Phase I

Contract Number: EPD17013
Start Date: 11/1/2016    Completed: 4/30/2017
Phase I year
2016
Phase I Amount
$99,857
TIAX has developed a technology that meets the EPA' s need for decontamination of biological material in railway and subway cars. It provides simultaneous encapsulation and killing of biological contaminants with the added capability for decontamination of chemical and radiological hazards. Current technologies are manpower intensive involving separate steps for site preparation; decontamination; wash-down; and recovery for waste disposal. The TIAX technology combines tasks and reduces the manpewer necessary to complete the remediation. In additiorr, it requires a: smaller logistical response; the remediation process provides protection against worker exposure and environmental cross-contarriination; and reduces hazardous waste disposal volumes versus typical liquid wash-down. TIAX's past research shows essentially complete removal of hazards with a demonstrated 7-log kill of Bacillus atrophaeus and 99.99% removal/recovery for methyl salicylate (at 4g/m2). The technology may be used in response to hazardous material releases in buildings and transportation systems, including trains, buses and aircraft. The technology is transferable to mold remediation with a reported 2003 market of $1.3B. End users include: hazardous materials removal companies for largescale hazmat and mold remediation responses; and home owners on smaller clean-up projects. TIAX has received interest from manufacturers in adding this technology to their existing product lines.

Phase II

Contract Number: EPD18005
Start Date: 2/1/2018    Completed: 3/13/2018
Phase II year
2017
Phase II Amount
$299,938
TIAX has developed a technology to meet EPA and homeland security needs for bio-agent decontamination in railway cars and other situations. It provides simultaneous encapsulation and killing of biological contaminants with the added capability for decontamination of chemical and radiological hazards. Current technologies are labor-intensive involving separate steps for site preparation, decontamination, wash-down, and waste disposal. TIAX’s technology combines tasks, reduces labor, and requires a smaller logistical response. The remediation process provides protection against worker exposure and environmental cross-contamination; and reduces hazardous waste disposal volumes versus typical liquid wash-down. TIAX’s past research shows essentially complete removal of hazards with a demonstrated 7-log kill of Bacillus atrophaeus. The technology may be used in response to hazardous material releases in buildings and transportation systems, including trains, buses and aircraft. According to an independent technology commercialization assessment, the technology is transferable to the Environmental Services Market (e.g., mold remediation and asbestos abatement) with a reported 2013 market approaching of $2.1B and the hazardous waste market of $25.9B in 2014. End users include hazmat companies for commercial remediation response and homeowners for smaller clean-up projects at hardware retailers. TIAX has received interest from manufacturers in adding this technology to their existing product lines.